NFKB1 and myasthenia gravis: Taken together, in the present study, we uncovered the anti-inflammatory effect of fluoxetine in MG under the challenge of OGD/R, an in vitro model of cerebral ischemia/reperfusion, as well as its specific mechanism related to the regulation of NF-κB-mediated signaling.